[go: up one dir, main page]

HN2002000218A - METHOD FOR THE TREATMENT OF PRIMARY INSOMNIA - Google Patents

METHOD FOR THE TREATMENT OF PRIMARY INSOMNIA

Info

Publication number
HN2002000218A
HN2002000218A HN2002000218A HN2002000218A HN2002000218A HN 2002000218 A HN2002000218 A HN 2002000218A HN 2002000218 A HN2002000218 A HN 2002000218A HN 2002000218 A HN2002000218 A HN 2002000218A HN 2002000218 A HN2002000218 A HN 2002000218A
Authority
HN
Honduras
Prior art keywords
treatment
melatonergic
primary insomnia
melatonin
agents
Prior art date
Application number
HN2002000218A
Other languages
Spanish (es)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Priority to HN2002000218A priority Critical patent/HN2002000218A/en
Publication of HN2002000218A publication Critical patent/HN2002000218A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL PRESENTE INVENTO SE REFIERE A UN MEDICAMENTO PARA EL TRATAMIENTO Y LA MEJORA DE LA CALIDAD REPARADORA DEL SUEÑO EN PACIENTES QUE SUFREN DE INSOMNIO PRIMARIO, QUE COMPRENDE AL MENOS UN COMPUESTO SELECCIONADO ENTRE MELATONINA, OTROS AGENTES MELATONERGICOS, AGONISTAAS DE LA MELATONINA Y ANTAGONISTAS DE LA MELATONINA EN UNA CANTIDAD EFICAZ DENTRO DE UN ENTORNO DE0, 0025 A 50 mg Y OPPTATIVAMENTE OTRO U OTROS AGENTES TERAPEUTICAMENTE ACTIVOS.THE PRESENT INVENTION REFERS TO A DRUG FOR THE TREATMENT AND IMPROVEMENT OF THE REPAIRING QUALITY OF SLEEP IN PATIENTS SUFFERING FROM PRIMARY INSOMNIA, WHICH INCLUDES AT LEAST ONE COMPOUND SELECTED FROM MELATONIN, OTHER AGENTS OF MELATONERGIC MELATONERGIC AGONISM, AND MELATONERGIC AGONENTS. MELATONIN IN AN EFFECTIVE AMOUNT WITHIN A SETTING OF 0.0025 TO 50 mg AND OPPTATIVELY OTHER OR OTHER THERAPEUTICALLY ACTIVE AGENTS.

HN2002000218A 2002-08-14 2002-08-14 METHOD FOR THE TREATMENT OF PRIMARY INSOMNIA HN2002000218A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HN2002000218A HN2002000218A (en) 2002-08-14 2002-08-14 METHOD FOR THE TREATMENT OF PRIMARY INSOMNIA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HN2002000218A HN2002000218A (en) 2002-08-14 2002-08-14 METHOD FOR THE TREATMENT OF PRIMARY INSOMNIA

Publications (1)

Publication Number Publication Date
HN2002000218A true HN2002000218A (en) 2003-04-22

Family

ID=53183909

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000218A HN2002000218A (en) 2002-08-14 2002-08-14 METHOD FOR THE TREATMENT OF PRIMARY INSOMNIA

Country Status (1)

Country Link
HN (1) HN2002000218A (en)

Similar Documents

Publication Publication Date Title
CY1124763T1 (en) METHOD FOR THE THERAPEUTIC TREATMENT OF PRIMARY INSOMNIA
CO5601022A2 (en) METHODS TO TREAT PATIENTS WHO ARE MOVING DISORDERS
AR068185A1 (en) COMPOSITIONS OF LAMOTRIGIN ORAL DISINTEGRATION TABLETS
AR049985A1 (en) COMBINATION TREATMENT FOR NON-HEMATOLOGICAL MALIGNAL DISEASES
AR109605A2 (en) METHOD FOR TREATING PERIPHERAL VASCULAR DISEASES, COMPOSITION AND USE
DE602005018763D1 (en) DOPAMINE AGONIST COMBINATION THERAPY WITH SEDATIVA TO IMPROVE THE SLEEP QUALITY
SG148202A1 (en) Quinazolinone compounds as anticancer agents
AR048833A1 (en) PROCEDURE FOR THE TREATMENT OF PREMENSTRUAL DISORDERS AND OTHER FEMALE SEXUAL DISORDERS
BE2012C040I2 (en)
AR060019A1 (en) PHARMACEUTICAL COMPOSITION, PRODUCT AND TREATMENT METHOD FOR A COGNITIVE DISORDER AND USES OF AN ACETILCOLINESTERASE INHIBITOR AND A 5- HT6 ANTAGONIST IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A COGNITIVE DISORDER
CY1112689T1 (en) COMPOSITION TO IMPROVE KNOWLEDGE AND MEMORY
TW200616608A (en) Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
ECSP066575A (en) BRADIQUININE B1 RECEIVER ANTAGONISTS
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
AR023687A1 (en) A COMPOSITION FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS AND THE USE OF A GLUTAMATE ANTAGONIST FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS
HN2002000218A (en) METHOD FOR THE TREATMENT OF PRIMARY INSOMNIA
CL2009000986A1 (en) Use of pai-1 inhibitors for the preparation of a drug useful in the treatment of ocular hypertension and glaucoma
AR039162A1 (en) VENLAFAXINA FORMULATIONS OF EXTENDED LIBERATION
AR044675A1 (en) METHOD FOR THE TREATMENT OF SCHIZOPHRENIA IN A PATIENT WITH OVERWEIGHT
AR074246A1 (en) DERIVATIVES OF 1-AMINO-ALQUILCICLOHEXANO FOR THE TREATMENT OF SOIL DISORDERS
ES2186153T3 (en) SULFATE 5-ALFA-PREGNAN-3-BETA-OL-20-ONA FOR THE TREATMENT OF TUMORS AND CNS DISORDERS.
RU2007100837A (en) METHOD FOR TREATING ALVEOLAR NERVE NEURITIS, CAUSED BY DISCLOSURE OF FILLING MATERIAL IN THE MANDIBULAR CHANNEL
BR0307413A (en) Aldosterone blocker therapy for prevention or treatment of inflammation-related conditions
AR043241A1 (en) COMBINED THERAPY THAT INCLUDES AN INDOLPIRROL-CARBAZOL DERIVATIVE AND ANOTHER ANTITUMORAL AGENT
DOP2003000756A (en) ADMINISTRATION OF A COMBINATION OF AN INDOLINONE WITH A CHEMOTHERAPEUTIC AGENT FOR THE DISORDERS OF THE CELL PROLIFERATION